Dr. Annamaria Piscazzi is a PhD Biologist Researcher with extensive oncology research experience since 2004. Her work includes studying retrotranscriptase inhibitors in various cancers (2004-2007) and investigating TRAP-1's role in cancer (2010-2019) with AIRC and LILT founding. She held fellowships (2020-2022) focused on drug resistance and currently holds a research position (SSD in MED/26) on the “HEAL ITALIA” precision medicine project (2023-present). Dr. Piscazzi also has teaching experience and has co-authored 35 publications (H-index 21, 1274 citations), including first-author papers in leading journals and a book chapter.
University of Foggia
Foggia, Puglia, Italy
DEP. Clinical and Experimental Medicine